SOdium LOading in Microgravity (SOLO) - 01.09.14

Overview | Description | Applications | Operations | Results | Publications | Imagery

ISS Science for Everyone

Science Objectives for Everyone SOdium LOading in Microgravity (SOLO) studies the mechanisms of fluid and salt retention in the body during space flight.

Science Results for Everyone Information Pending



This content was provided by Martina A. Heer, Ph.D., and is maintained in a database by the ISS Program Science Office.
Information provided courtesy of the Erasmus Experiment Archive.

Experiment Details

OpNom:

Principal Investigator(s)

  • Martina A. Heer, Ph.D., Institute of Aerospace Medicine German Aerospace Center, Cologne, Germany
  • Co-Investigator(s)/Collaborator(s)

  • N. Kamps, Germany
  • Natalie Baecker, Institute of Aerospace Medicine, Cologne, Germany
  • Peter Norsk, M.D., University of Copenhagen, Copenhagen, Denmark
  • Petra Frings-Meuthen, Institute of Aerospace Medicine, Cologne, Germany
  • Developer(s)
    Information Pending

    Sponsoring Space Agency
    European Space Agency (ESA)

    Sponsoring Organization
    Information Pending

    Research Benefits
    Information Pending

    ISS Expedition Duration:
    April 2008 - September 2012

    Expeditions Assigned
    17,18,19/20,23/24,25/26,27/28,29/30,31/32

    Previous ISS Missions

    SOLO was first operated on ISS Expedition 17.

    ^ back to top



    Experiment Description

    Research Overview

    • Microgravity leads to an activation of sodium retaining hormones even at normal sodium intake levels and causes positive sodium balances. Average and high sodium intake in microgravity exacerbates the rise in bone resorption in space.


    • SOdium LOading in Microgravity (SOLO) is a continuation of extensive research into the mechanisms of fluid and salt retention in the body during bed rest and space flights; It is a metabolically controlled study.


    • During long-term space missions crewmembers will participate in two study phases, 5 days each. Subjects follow a diet of constant either low or normal sodium intake and increased fluid consumption.

    Description
    The hypothesis of an increased urine flow as the main cause for body mass decrease has been questioned in several recently flown missions. Data from the American SLS1/2 missions as well as the European Euromir `94 and MIR 97 mission show that urine flow and total body fluid is unchanged when isocaloric energy intake is achieved.

    However, in two astronauts during these missions the renin-angiotensin system was considerably activated while plasma ANP concentrations were decreased. Calculation of daily sodium balances during a 15 day experiment of the MIR 97 mission, by subtracting sodium excretion from sodium intake- showed an astonishing result: the astronaut retained on average 50 mmol sodium daily in space compared to balanced sodium in the control experiment.

    ^ back to top



    Applications

    Space Applications
    Information Pending

    Earth Applications
    Information Pending

    ^ back to top



    Operations

    Operational Requirements
    Information Pending

    Operational Protocols
    Information Pending

    ^ back to top



    Results/More Information

    ^ back to top



    Related Websites

    ^ back to top



    Imagery

    image NASA Image: ISS017E018995 - Astronaut Greg Chamitoff, Expedition 17 Flight Engineer (FE) in the Kibo European Laboratory/Columbus. The Space Linear Acceleration Mass Measurement Device (SLAMMD) is visible on the left of frame.
    + View Larger Image